Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
Net Income (Common)
Edwards Lifesciences Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Edwards Lifesciences Corp
NYSE:EW
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Edwards Lifesciences Corp's Net Income (Common)?
Net Income (Common)
1.4B
USD
Based on the financial report for Dec 31, 2023, Edwards Lifesciences Corp's Net Income (Common) amounts to 1.4B USD.
What is Edwards Lifesciences Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
14%
Over the last year, the Net Income (Common) growth was -8%. The average annual Net Income (Common) growth rates for Edwards Lifesciences Corp have been 19% over the past three years , 14% over the past five years , and 14% over the past ten years .